Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Physiomics (PYC)

Price 1.30p on 28-03-2024 at 17:30:03
Change 0.00p 0%
Buy 1.40p
Sell 1.20p
Buy / Sell PYC Shares
Last Trade: Sell 41,584.00 at 1.20p
Day's Volume: 333,263
Last Close: 1.30p
Open: 1.30p
ISIN: GB00BDR6W943
Day's Range 1.30p - 1.30p
52wk Range: 0.925p - 4.15p
Market Capitalisation: £2m
VWAP: 1.234195p
Shares in Issue: 135m

Recent Trades History Physiomics (PYC)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 41,584 1.20p Ordinary
16:18:33 - 28-Mar-24
Sell* 62,500 1.20p Ordinary
16:16:10 - 28-Mar-24
Buy* 15,094 1.325p Ordinary
15:05:40 - 28-Mar-24
Sell* 2,285 1.20p Ordinary
14:44:35 - 28-Mar-24
Sell* 53,219 1.23p Ordinary
13:21:56 - 28-Mar-24
Buy* 48,096 1.33p Ordinary
12:25:45 - 28-Mar-24
Sell* 2,778 1.216p Ordinary
10:12:43 - 28-Mar-24
Sell* 100,000 1.215p Ordinary
10:10:49 - 28-Mar-24
Sell* 7,707 1.215p Ordinary
09:43:58 - 28-Mar-24

Share Price History for Physiomics

Time period:
to
Date Open High Low Close Volume

Share News for Physiomics

IN BRIEF: Physiomics celebrates "substantial" contract with old client

18th Mar 2024 11:57

Physiomics PLC - mathematical modelling company that supports oncology drug development - Receives a "substantial" new contract by an existing "large pharma" client, though doesn't specify whom the client is. The project, which is valued at GBP178,000, involves involves pharmacokinetic-pharmacodynamic modelling in the field of DNA damage and repair fields. It is designed to help inform clinical dose and scheduling decisions. Physiomics expects this work to be completed over the course of the next six months. Read More

Physiomics reports higher interim revenue; loss narrows

7th Mar 2024 14:24

(Alliance News) - Physiomics PLC on Thursday reported higher interim revenue and a narrowed loss. Read More

UK earnings, trading statements calendar - next 7 days

4th Mar 2024 16:21

Read More

Physiomics celebrates contract award for cancer therapy insect model

19th Feb 2024 10:30

(Alliance News) - Physiomics PLC on Monday said that it has been awarded a contract by the University of Sheffield to support a grant-funded project focused on an insect model of cancer treatment. Read More

IN BRIEF: Physiomics wins deal to support client's oncology assets

5th Feb 2024 11:21

Physiomics PLC - mathematical modelling company that supports oncology drug development - Wins further contract from existing client Numab Therapeutics AG. Says the project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's oncology assets entering the clinic and will help inform dose and scheduling decisions. Chief Executive Officer Peter Sargent comments: "We are thrilled to have this opportunity to continue working with and supporting Numab on this asset through its preclinical stages as it heads into the clinic. Along with the project we announced with them in August 2023, this new project is testament to the continued support we provide and the great relationships we've built." Read More

FTSE 100 Latest
Value7,952.62
Change20.64

Login to your account

Forgot Password?

Not Registered